Publication | Closed Access

Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial

Percutaneous Coronary InterventionCardiovascular DiseaseIncomplete RevascularisationPlacebo-controlled TrialPharmacotherapyAcute Myocardial InfarctionMedicineCardiologyCoronary Artery DiseaseAnesthesiologyMyocardial Infarction